Literature DB >> 28340083

Evaluating the Patterns of Aging-Related Tau Astrogliopathy Unravels Novel Insights Into Brain Aging and Neurodegenerative Diseases.

Gabor G Kovacs1,2, John L Robinson2, Sharon X Xie3, Edward B Lee2, Murray Grossman4, David A Wolk4, David J Irwin4, Dan Weintraub5, Christopher F Kim2, Theresa Schuck2, Ahmed Yousef2, Stephanie T Wagner1, Eunran Suh2, Vivianna M Van Deerlin2, Virginia M-Y Lee2, John Q Trojanowski2.   

Abstract

The term "aging-related tau astrogliopathy" (ARTAG) describes pathological accumulation of abnormally phosphorylated tau protein in astrocytes. We evaluated the correlates of ARTAG types (i.e., subpial, subependymal, white and gray matter, and perivascular) in different neuroanatomical regions. Clinical, neuropathological, and genetic (eg, APOE ε4 allele, MAPT H1/H2 haplotype) data from 628 postmortem brains from subjects were investigated; most of the patients had been longitudinally followed at the University of Pennsylvania. We found that (i) the amygdala is a hotspot for all ARTAG types; (ii) age at death, male sex, and presence of primary frontotemporal lobar degeneration (FTLD) tauopathy are significantly associated with ARTAG; (iii) age at death, greater degree of brain atrophy, ventricular enlargement, and Alzheimer disease (AD)-related variables are associated with subpial, white matter, and perivascular ARTAG types; (iv) AD-related variables are associated particularly with lobar white matter ARTAG; and (v) gray matter ARTAG in primary FTLD-tauopathies appears in areas without neuronal tau pathology. We provide a reference map of ARTAG types and propose at least 5 constellations of ARTAG. Furthermore, we propose a conceptual link between primary FTLD-tauopathy and ARTAG-related astrocytic tau pathologies. Our observations serve as a basis for etiological stratification and definition of progression patterns of ARTAG.
© 2017 American Association of Neuropathologists, Inc. All rights reserved.

Entities:  

Keywords:  ARTAG; Aging-related tau astrogliopathy; Alzheimer disease; Chronic traumatic encephalopathy; Dementia; Tau; Tauopathy

Mesh:

Substances:

Year:  2017        PMID: 28340083      PMCID: PMC6251691          DOI: 10.1093/jnen/nlx007

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  65 in total

1.  Glial and neuronal tau pathology in tauopathies: characterization of disease-specific phenotypes and tau pathology progression.

Authors:  Isidre Ferrer; Irene López-González; Margarita Carmona; Laura Arregui; Esther Dalfó; Benjamin Torrejón-Escribano; Roberta Diehl; Gabor G Kovacs
Journal:  J Neuropathol Exp Neurol       Date:  2014-01       Impact factor: 3.685

Review 2.  Pick's disease: a modern approach.

Authors:  D W Dickson
Journal:  Brain Pathol       Date:  1998-04       Impact factor: 6.508

3.  Astrocytes expressing hyperphosphorylated tau protein without glial fibrillary tangles in argyrophilic grain disease.

Authors:  G Botez; A Probst; S Ipsen; M Tolnay
Journal:  Acta Neuropathol       Date:  1999-09       Impact factor: 17.088

4.  Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias.

Authors:  Mark Yarchoan; Sharon X Xie; Mitchel A Kling; Jon B Toledo; David A Wolk; Edward B Lee; Vivianna Van Deerlin; Virginia M-Y Lee; John Q Trojanowski; Steven E Arnold
Journal:  Brain       Date:  2012-11-30       Impact factor: 13.501

5.  17q21.31 duplication causes prominent tau-related dementia with increased MAPT expression.

Authors:  K Le Guennec; O Quenez; G Nicolas; D Wallon; S Rousseau; A-C Richard; J Alexander; P Paschou; C Charbonnier; C Bellenguez; B Grenier-Boley; D Lechner; M-T Bihoreau; R Olaso; A Boland; V Meyer; J-F Deleuze; P Amouyel; H M Munter; G Bourque; M Lathrop; T Frebourg; R Redon; L Letenneur; J-F Dartigues; O Martinaud; O Kalev; S Mehrabian; L Traykov; T Ströbel; I Le Ber; P Caroppo; S Epelbaum; T Jonveaux; F Pasquier; A Rollin-Sillaire; E Génin; L Guyant-Maréchal; G G Kovacs; J-C Lambert; D Hannequin; D Campion; A Rovelet-Lecrux
Journal:  Mol Psychiatry       Date:  2016-12-13       Impact factor: 15.992

6.  Argyrophilic thorny astrocyte clusters in association with Alzheimer's disease pathology in possible primary progressive aphasia.

Authors:  David G Munoz; John Woulfe; Andrew Kertesz
Journal:  Acta Neuropathol       Date:  2007-07-19       Impact factor: 17.088

7.  Deep clinical and neuropathological phenotyping of Pick disease.

Authors:  David J Irwin; Johannes Brettschneider; Corey T McMillan; Felicia Cooper; Christopher Olm; Steven E Arnold; Vivianna M Van Deerlin; William W Seeley; Bruce L Miller; Edward B Lee; Virginia M-Y Lee; Murray Grossman; John Q Trojanowski
Journal:  Ann Neurol       Date:  2015-12-25       Impact factor: 10.422

8.  White matter tauopathy with globular glial inclusions: a distinct sporadic frontotemporal lobar degeneration.

Authors:  Gabor G Kovacs; Katalin Majtenyi; Salvatore Spina; Jill R Murrell; Ellen Gelpi; Romana Hoftberger; Graham Fraser; R Anthony Crowther; Michel Goedert; Herbert Budka; Bernardino Ghetti
Journal:  J Neuropathol Exp Neurol       Date:  2008-10       Impact factor: 3.685

9.  The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts.

Authors:  Amanda J Myers; Alan M Pittman; Alice S Zhao; Kristen Rohrer; Mona Kaleem; Lauren Marlowe; Andrew Lees; Doris Leung; Ian G McKeith; Robert H Perry; Chris M Morris; John Q Trojanowski; Christopher Clark; Jason Karlawish; Steve Arnold; Mark S Forman; Vivianna Van Deerlin; Rohan de Silva; John Hardy
Journal:  Neurobiol Dis       Date:  2006-12-15       Impact factor: 5.996

10.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.

Authors:  Heiko Braak; Irina Alafuzoff; Thomas Arzberger; Hans Kretzschmar; Kelly Del Tredici
Journal:  Acta Neuropathol       Date:  2006-08-12       Impact factor: 17.088

View more
  40 in total

1.  Connexin-43 and aquaporin-4 are markers of ageing-related tau astrogliopathy (ARTAG)-related astroglial response.

Authors:  G G Kovacs; A Yousef; S Kaindl; V M Lee; J Q Trojanowski
Journal:  Neuropathol Appl Neurobiol       Date:  2017-08-25       Impact factor: 8.090

Review 2.  Protein astrogliopathies in human neurodegenerative diseases and aging.

Authors:  Gabor G Kovacs; Virginia M Lee; John Q Trojanowski
Journal:  Brain Pathol       Date:  2017-09       Impact factor: 6.508

3.  Alzheimer's disease neuropathology may not predict functional impairment in HIV: a report of two individuals.

Authors:  Susan Morgello; Michelle Jacobs; Jacinta Murray; Desiree Byrd; Eric Neibart; Letty Mintz; Gregory Meloni; Christina Chon; John Crary
Journal:  J Neurovirol       Date:  2018-08-09       Impact factor: 2.643

4.  Language and spatial dysfunction in Alzheimer disease with white matter thorn-shaped astrocytes.

Authors:  Elisa de Paula França Resende; Amber L Nolan; Cathrine Petersen; Alexander J Ehrenberg; Salvatore Spina; Isabel E Allen; Howard J Rosen; Joel Kramer; Bruce L Miller; William W Seeley; Maria Luiza Gorno-Tempini; Zachary Miller; Lea T Grinberg
Journal:  Neurology       Date:  2020-01-30       Impact factor: 9.910

5.  CNS inflammation and neurodegeneration.

Authors:  Tanuja Chitnis; Howard L Weiner
Journal:  J Clin Invest       Date:  2017-09-05       Impact factor: 14.808

6.  Mechanical disruption of the blood-brain barrier following experimental concussion.

Authors:  Victoria E Johnson; Maura T Weber; Rui Xiao; D Kacy Cullen; David F Meaney; William Stewart; Douglas H Smith
Journal:  Acta Neuropathol       Date:  2018-02-19       Impact factor: 17.088

7.  Multisite Assessment of Aging-Related Tau Astrogliopathy (ARTAG).

Authors:  Gabor G Kovacs; Sharon X Xie; Edward B Lee; John L Robinson; Carrie Caswell; David J Irwin; Jon B Toledo; Victoria E Johnson; Douglas H Smith; Irina Alafuzoff; Johannes Attems; Janos Bencze; Kevin F Bieniek; Eileen H Bigio; Istvan Bodi; Herbert Budka; Dennis W Dickson; Brittany N Dugger; Charles Duyckaerts; Isidro Ferrer; Shelley L Forrest; Ellen Gelpi; Stephen M Gentleman; Giorgio Giaccone; Lea T Grinberg; Glenda M Halliday; Kimmo J Hatanpaa; Patrick R Hof; Monika Hofer; Tibor Hortobágyi; James W Ironside; Andrew King; Julia Kofler; Enikö Kövari; Jillian J Kril; Seth Love; Ian R Mackenzie; Qinwen Mao; Radoslav Matej; Catriona McLean; David G Munoz; Melissa E Murray; Janna Neltner; Peter T Nelson; Diane Ritchie; Roberta D Rodriguez; Zdenek Rohan; Annemieke Rozemuller; Kenji Sakai; Christian Schultz; Danielle Seilhean; Vanessa Smith; Pawel Tacik; Hitoshi Takahashi; Masaki Takao; Dietmar Rudolf Thal; Serge Weis; Stephen B Wharton; Charles L White; John M Woulfe; Masahito Yamada; John Q Trojanowski
Journal:  J Neuropathol Exp Neurol       Date:  2017-07-01       Impact factor: 3.685

8.  Modeling the Long-Term Consequences of Repeated Blast-Induced Mild Traumatic Brain Injuries.

Authors:  Denes V Agoston
Journal:  J Neurotrauma       Date:  2017-09       Impact factor: 5.269

9.  Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders.

Authors:  David Coughlin; Sharon X Xie; Mendy Liang; Andrew Williams; Claire Peterson; Daniel Weintraub; Corey T McMillan; David A Wolk; Rizwan S Akhtar; Howard I Hurtig; H Branch Coslett; Roy H Hamilton; Andrew D Siderowf; John E Duda; Katya Rascovsky; Edward B Lee; Virginia M-Y Lee; Murray Grossman; John Q Trojanowski; David J Irwin
Journal:  Ann Neurol       Date:  2019-01-07       Impact factor: 10.422

10.  Tau immunophenotypes in chronic traumatic encephalopathy recapitulate those of ageing and Alzheimer's disease.

Authors:  John D Arena; Douglas H Smith; Edward B Lee; Garrett S Gibbons; David J Irwin; John L Robinson; Virginia M-Y Lee; John Q Trojanowski; William Stewart; Victoria E Johnson
Journal:  Brain       Date:  2020-05-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.